Cargando…

Reply to ‘Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’ ’

Detalles Bibliográficos
Autores principales:	Waked, Iman, Johnson, Philip J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680455/ https://www.ncbi.nlm.nih.gov/pubmed/28772278 http://dx.doi.org/10.1038/bjc.2017.241

Ejemplares similares

Comment on ‘Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion’
por: Huo, Teh-Ia, et al.
Publicado: (2017)

Transarterial chemo-embolisation of hepatocellular carcinoma: impact of liver function and vascular invasion
por: Waked, Imam, et al.
Publicado: (2017)

Associating liver partition and portal vein ligation or combined transarterial chemo-embolisation and portal vein embolisation for staged hepatectomy for HBV-related hepatocellular carcinoma
por: Gavriilidis, Paschalis, et al.
Publicado: (2023)

Reply to: Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Johnson, Philip, et al.
Publicado: (2016)

Sorafenib with or without concurrent transarterial chemoembolization in hepatocellular carcinoma: a cautionary comment of STAH trial
por: Chen, Jia-Hao, et al.
Publicado: (2020)

Transarterial embolisation of hepatocellular carcinoma with doxorubicin-eluting beads: single centre early experience
por: Nawawi, O, et al.
Publicado: (2010)

Outcomes of Transarterial Embolisation (TAE) vs. Transarterial Chemoembolisation (TACE) for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
por: Lawson, Alexander, et al.
Publicado: (2023)

A simple prognostic scoring system for patients receiving transarterial embolisation for hepatocellular cancer
por: Kadalayil, L., et al.
Publicado: (2013)

Reply to: Comment on ‘Tumour antigen expression in hepatocellular carcinoma in a low-endemic western area'
por: Sideras, Kostandinos, et al.
Publicado: (2016)

Author reply to comments
por: Bhalla, Ashu Seith, et al.
Publicado: (2015)

Early Experience of Trans-arterial Chemo-Embolisation for Hepatocellular Carcinoma with a Novel Radiopaque Bead
por: Reicher, John, et al.
Publicado: (2019)

Reply to: Comments on “Association of liver abnormalities with in-hospital mortality in patients with COVID-19”
por: Ding, Ze-yang, et al.
Publicado: (2021)

Comments on Relationship between the High Fatty Liver Index and Risk of Fracture: Reply
por: Kim, Min-Ji, et al.
Publicado: (2023)

Comment on “Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis”
por: Tang, Xiao-Long, et al.
Publicado: (2022)

Reply to comment of Prof. Artur Czekierdowski
por: Jakiel, Grzegorz
Publicado: (2017)

Reply to the comment by Osuka et al.
por: Endo, Akira, et al.
Publicado: (2020)

Comment on a meta-analysis comparing hepatic resection or transarterial chemoembolization as initial treatment for hepatocellular carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Uterine artery embolisation as management of postoperative gynaecological haemorrhage
por: García, Jessica Nogueira, et al.
Publicado: (2015)

Reply: Surgery vs chemoRT for locally advanced operable head and neck cancers
por: Soo, K C, et al.
Publicado: (2006)

Reply: Comment on alemtuzumab and inclusion body myositis
por: Dalakas, Marinos C., et al.
Publicado: (2010)

Authors' Reply to Comments from Dr. Guan
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Redefining vitamin D deficiency: Reply to comments
por: Garg, MK, et al.
Publicado: (2014)

Reply to Comment on: Fungal keratitis: The Aravind Experience
por: Prajna, Venkatesh N, et al.
Publicado: (2018)

Authors’ Reply to Comments on ASHAs’ Perceptions on Depression
por: Mary Kapanee, Aruna Rose, et al.
Publicado: (2018)

Reply to Comment on “Osteoporosis in the Age of COVID-19”
por: Girgis, C. M., et al.
Publicado: (2021)

Uterine fibroid embolisation: advocating women’s choice for uterine salvage
por: Clements, Warren
Publicado: (2020)

Treatment of hepatic metastases from medullary thyroid cancer with transarterial embolisation
por: Hughes, Peter, et al.
Publicado: (2017)

Transarterial Embolisation of a Gastroduodenal Artery Pseudoaneurysm Rupture Into the Portal Vein
por: Sarkadi, Hunor, et al.
Publicado: (2023)

Reply to Comment on ‘Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'
por: Heil, Joerg
Publicado: (2016)

Is transarterial embolization plus two-stage hepatectomy the optimal strategy for the treatment of spontaneous rupture of hepatocellular carcinoma?
por: He, Tao, et al.
Publicado: (2023)

Comment on: ‘Long-term impact of liver function on curative therapy for hepatocellular carcinoma: application of the ALBI grade'
por: Cucchetti, Alessandro, et al.
Publicado: (2016)

Reply to comment: Conventional manual small-incision cataract surgery
por: Yang, Jun, et al.
Publicado: (2015)

Author reply to comment on photodynamic therapy and polypoidal choroidal vasculopathy
por: Williams, Gwyn Samuel, et al.
Publicado: (2014)

Anaesthetic management of a case of adrenal and extra-adrenal phaeochromocytoma for preoperative embolisation
por: Jacob, Mathews, et al.
Publicado: (2015)

Reply: A morpho-molecular prognostic model for hepatocellular carcinoma
por: Srivastava, S, et al.
Publicado: (2013)

Reply to: “Malignant transformation of hepatocellular adenoma”
por: Chopinet, Sophie, et al.
Publicado: (2022)

Imaging evaluation following transarterial radioembolization with yttrium-90 microspheres downstaging hepatocellular carcinoma: the first case in China
por: Li, Xiaoming, et al.
Publicado: (2023)

Reply to: “Comment on “Quality of life and unmet needs in patients with chronic liver disease: A mixed-method systematic review””
por: Grønkjær, Lea Ladegaard, et al.
Publicado: (2021)

Reply: Comment on ‘Beta-blockers increase response to chemotherapy via direct anti-tumour and anti-angiogenic mechanisms in neuroblastoma' – β-blockers are potent anti-angiogenic and chemo-sensitising agents, rather than cytotoxic drugs
por: Pasquier, E, et al.
Publicado: (2013)

Reply to ‘Comment on Cancer incidence in the United Kingdom: projections to the year 2030'
por: Ahmad, A S, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6h6lgn03rsptbpod5h9chak11t